BDBM704410 N-(1-Cyclopropyl-2-oxo-1,2-dihydropyridin-3-yl)-2-((1r,4r)-4-((4-(2-(2,6-dioxopiperidin-3-yl)-7-methoxy-1-oxoisoindolin-5-yl)piperazin-1-yl)methyl)cyclohexyl)-6-methoxy-2H-indazole-5-carboxamide::US20240374588, Example 81

SMILES COC1=CC(=N)/C(=CN[C@H]2CC[C@H](CN3CCN(c4cc5c(c(OC)c4)C(=O)N(C4CCC(=O)NC4=O)C5)CC3)CC2)C=C1C(=O)Nc1cccn(C2CC2)c1=O

InChI Key InChIKey=WPTNLUDHNWANPM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 704410   

TargetInterleukin-1 receptor-associated kinase 4(Human)
Astrazeneca

US Patent
LigandPNGBDBM704410(N-(1-Cyclopropyl-2-oxo-1,2-dihydropyridin-3-yl)-2-...)
Affinity DataIC50: 2.70nMAssay Description:The inhibitory activity of compounds against IRAK4 were determined in an enzymatic assay using mass spectrometry readout. Ten point half-log compound...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/20/2025
Entry Details
Go to US Patent